CPT1A and Familial prostate cancer: Prostate cancer cells may have less vitality after therapy with etomoxir, irreversible inhibitor of CPT1A, and etomoxir treatment in mice reduced xenograft growth for a period of 21 days (Schlaepfer et al., 2014).